Clinical Trial Update: BENEFIT Extension Study

View source ↗

Summary

The BENEFIT Extension Study in multiple sclerosis has completed, offering additional follow-up data from the original trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Bayer | Conditions: Multiple Sclerosis | Status: COMPLETED